Free Trial
OTCMKTS:PPCB

Propanc Biopharma (PPCB) Stock Price, News & Analysis

Propanc Biopharma logo
$3.37 -0.69 (-17.00%)
As of 08/22/2025 04:00 PM Eastern

About Propanc Biopharma Stock (OTCMKTS:PPCB)

Key Stats

Today's Range
$3.15
$4.00
50-Day Range
$2.87
$10.40
52-Week Range
$1.25
$145.46
Volume
1.30 million shs
Average Volume
885,697 shs
Market Capitalization
$64.03 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PPCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PPCB Stock News Headlines

Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Propanc Biopharma Inc
See More Headlines

PPCB Stock Analysis - Frequently Asked Questions

Propanc Biopharma's stock was trading at $0.0002 at the start of the year. Since then, PPCB stock has increased by 1,684,900.0% and is now trading at $3.37.

Propanc Biopharma Inc (OTCMKTS:PPCB) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($12.50) earnings per share (EPS) for the quarter.

Propanc Biopharma's stock reverse split on Tuesday, May 23rd 2023.The 1-1000 reverse split was announced on Tuesday, May 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Propanc Biopharma's quiet period expires on Wednesday, September 24th. Propanc Biopharma had issued 1,000,000 shares in its initial public offering on August 15th. The total size of the offering was $4,000,000 based on an initial share price of $4.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of PPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Propanc Biopharma investors own include T2 Biosystems (TTOO), AppYea (APYP), Avis Budget Group (CAR), PayPal (PYPL), Synthetic Biologics (SYN), Corbus Pharmaceuticals (CRBP) and Delcath Systems (DCTH).

Company Calendar

Last Earnings
5/15/2025
Today
8/23/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PPCB
CIK
1517681
Employees
1
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-3,652.66%
Return on Assets
-971.09%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
2.24
Quick Ratio
2.24

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($493.34) per share
Price / Book
-0.01

Miscellaneous

Outstanding Shares
19,000
Free Float
19,000
Market Cap
$64.03 thousand
Optionable
Not Optionable
Beta
2.78
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:PPCB) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners